Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10555-017-9661-5 http://scihub22266oqcxt.onion/10.1007/s10555-017-9661-5 C5385190!5385190!28283772     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Metastasis+Rev 2017 ; 36 (1): 77-90 Nephropedia Template TP {{tp|p=28283772|t=2017. Identification, genetic testing, and management of hereditary melanoma |pdf=|usr=}}{{28283772}} gab.com Text Identification, genetic testing, and management of hereditary melanoma JO: Cancer Metastasis Rev http://www.kidney.de/pget.php?&tw=1&pmid=28283772 #FOAvip Several distinct melanoma syndromes have been defined, and genetic tests are available for the associated causative genes. Guidelines for melanoma genetic testing have been published as an informal ?rule of twos and threes,? but these guidelines apply to CDKN2A testing and are not intended for the more recently described non-CDKN2A melanoma syndromes. In order to develop an approach for the full spectrum of hereditary melanoma patients, we have separated melanoma syndromes into two types: ?melanoma dominant? and ?melanoma subordinate.? Syndromes in which melanoma is a predominant cancer type are considered melanoma dominant, although other cancers, such as mesothelioma or pancreatic cancers, may also be observed. These syndromes are associated with defects in CDKN2A, CDK4, BAP1, MITF, and POT1. Melanoma-subordinate syndromes have an increased but lower risk of melanoma than that of other cancer(s) seen in the syndrome, such as breast and ovarian cancer or Cowden syndrome. Many of these melanoma-subordinate syndromes are associated with well-established predisposition genes (e.g., BRCA1/2, PTEN). It is likely that these predisposition genes are responsible for the increased susceptibility to melanoma as well but with lower penetrance than that observed for the dominant cancer(s) in those syndromes. In this review, we describe our extension of the ?rule of twos and threes? for melanoma genetic testing. This algorithm incorporates an understanding of the spectrum of cancers and genes seen in association with melanoma to create a more comprehensive and tailored approach to genetic testing. Twit Text FOAVip Identification, genetic testing, and management of hereditary melanoma ????Cancer Metastasis Rev http://www.kidney.de/pget.php?&tw=1&pmid=28283772 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28283772 #FOAvip English Wikipedia <ref>{{Cite pmid|28283772}}</ref> Identification, genetic testing, and management of hereditary melanoma #MMPMID28283772 Leachman SA; Lucero OM; Sampson JE; Cassidy P; Bruno W; Queirolo P; Ghiorzo P Cancer Metastasis Rev 2017[]; 36 (1): 77-90 PMID28283772show ga Several distinct melanoma syndromes have been defined, and genetic tests are available for the associated causative genes. Guidelines for melanoma genetic testing have been published as an informal ?rule of twos and threes,? but these guidelines apply to CDKN2A testing and are not intended for the more recently described non-CDKN2A melanoma syndromes. In order to develop an approach for the full spectrum of hereditary melanoma patients, we have separated melanoma syndromes into two types: ?melanoma dominant? and ?melanoma subordinate.? Syndromes in which melanoma is a predominant cancer type are considered melanoma dominant, although other cancers, such as mesothelioma or pancreatic cancers, may also be observed. These syndromes are associated with defects in CDKN2A, CDK4, BAP1, MITF, and POT1. Melanoma-subordinate syndromes have an increased but lower risk of melanoma than that of other cancer(s) seen in the syndrome, such as breast and ovarian cancer or Cowden syndrome. Many of these melanoma-subordinate syndromes are associated with well-established predisposition genes (e.g., BRCA1/2, PTEN). It is likely that these predisposition genes are responsible for the increased susceptibility to melanoma as well but with lower penetrance than that observed for the dominant cancer(s) in those syndromes. In this review, we describe our extension of the ?rule of twos and threes? for melanoma genetic testing. This algorithm incorporates an understanding of the spectrum of cancers and genes seen in association with melanoma to create a more comprehensive and tailored approach to genetic testing. äIdentification, genetic testing, and management of hereditary melanoma(epmc).pdf DeepDyve Pubget Overpricing